Nuestros recursos

NEW YORK – August 17, 2021 - Inc. Magazine today ranked ObvioHealth, a leading global Virtual Research Organization (VRO), at No. 390 on its annual list of the nation’s fastest-growing private companies, confirming ObvioHealth’s impressive growth in the decentralized clinical trials (DCT) space.

ObvioHealth looks to grow expertise in deep tech. We immediately recognized that Singapore could fill this need. Here, we can tap into a rich ecosystem of health tech companies and talent.

ObvioHealth, a global medical technology company, announces the launch of its mobile application for site-less clinical studies.

ObvioHealth, a global virtual research organization or VRO, today announced the launch of a hybrid clinical trial for the treatment of COVID-19, using an innovative study design with digital data capture to remotely monitor patient vitals.

ObvioHealth, a full-service virtual research organization (VRO), announces today a partnership with La Foundation Hôpital Paris Saint Joseph to monitor COVID-19

ObvioHealth, a leading virtual health research organization or VRO, announced today it has raised $17 million in its latest round of financing. This round of financing comes on the heels of a global alliance with a strategic partner announced in March.

Singapore and New-York, 2 April 2020 – ObvioHealth, a digital research company, announces the launch of a registry to monitor COVID-19 prevalence, symptoms and immune response in the United States over the coming 12 months.